What makes the device distinctive is this combination of alert modes
Scientists have designed an implantable medical device that alerts users about a potential heart attack through a combination of vibrations, audible tones, and visual warnings.
The
AngelMed Guardian is currently undergoing clinical trials.
What makes the device distinctive is this combination of alert modes. Although vibrotactile (vibrating) alarms are sometimes used to warn medical personnel in operating rooms or ICUs of an emergency, very little research has focused on their potential as a self-monitoring device for patients.
Auditory alarms are provided with selected implantable heart defibrillators, but research indicates that some patients - particularly the elderly - are unable to hear the alarms.
“A vibrotactile alarm provided by the implanted device has two major advantages. First, the implanted device can’t be left behind like a portable device. Second, a vibrotactile alarm from the implanted device is more likely to be felt than an auditory alarm is to be heard because, for example, the patient may be wearing heavy clothing, has hearing loss, or is in a noisy environment,” said Mary Carol Day, one of the researchers.
The device offers two levels of alarm urgency: A high-priority alarm indicates that the patient may be having a heart attack and should call 911, and a low-priority alarms indicates that a condition has been detected that requires a doctor visit within 48 hours.
The alarms are provided by an implanted medical device, similar in size to a pacemaker, that is placed in the upper left chest, plus an external device, similar to a pager, that emits an auditory alarm and flashes a red or yellow warning light.
In a series of studies with older adults designed to test the device’s design and user-friendliness, participants were able to tell the difference between the low-priority and high-priority vibration patterns and respond appropriately. They also reported that they liked the vibrating alarms and the redundancy of the auditory, visual, and vibrotactile warnings.
“If the Guardian is approved for sale by the FDA,” said Day, “it might be extended in ways that will change the way the patient interacts with the system as a whole. This would require more research and simulated-use studies to refine and validate the new interactions between the patient and the system.”
Detail of device will appear in an upcoming Ergonomics in Design article.
GMT 22:42 2018 Thursday ,13 December
'World of Food Abu Dhabi' kicks off at Umm Al Emarat ParkGMT 14:21 2018 Monday ,26 November
'Pandora's Box': Chinese scientists condemn human gene-editing claimGMT 10:45 2018 Thursday ,15 November
Major genes-focused testing for Aussies points to better treatment of rare cancersGMT 13:08 2018 Wednesday ,31 October
Syria participates in Global Parliamentary Summit against Hunger and MalnutritionGMT 12:57 2018 Wednesday ,24 October
Viral outbreak kills six children and left 12 more sick at New Jersey rehab centreGMT 15:42 2018 Saturday ,20 October
Marathon in Damascus to raise awareness about breast cancer early detectionGMT 12:44 2018 Wednesday ,17 October
Russia must be in the know on foreign labs dealing with biomaterials "health official"GMT 18:30 2018 Monday ,15 October
President Al-Bashir Affirms Sudan Commitment to Realize Universal Health CoverageMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor